# Diversified Healthcare Trust: overview

DHC · Nasdaq · CIK 1075415 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dhc.md) · [Financials](/companies/dhc/financials.md) · [Filings](/companies/dhc/filings.md) · [Insiders](/companies/dhc/insiders.md)

Latest reported revenue: [$365.4m](/filings/0001075415-26-000030.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001075415-26-000030).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [374](/filings/0001075415-25-000044.md) | [380 d](/filings/0001075415-26-000013.md) | [387](/filings/0001075415-26-000024.md) | [383](/filings/0001075415-26-000030.md) | [389](/filings/0001075415-25-000044.md) | [380 d](/filings/0001075415-26-000013.md) | [366](/filings/0001075415-26-000024.md) | [365](/filings/0001075415-26-000030.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(26.4%)](/filings/0001075415-25-000044.md) | [(23.0%) d](/filings/0001075415-26-000013.md) | [(2.3%)](/filings/0001075415-26-000030.md) | [(23.9%)](/filings/0001075415-26-000030.md) | [(42.2%)](/filings/0001075415-25-000044.md) | [(5.6%) d](/filings/0001075415-26-000013.md) | [(11.8%)](/filings/0001075415-26-000030.md) | [(10.2%)](/filings/0001075415-26-000030.md) |
| Diluted EPS | $ per share | [(0.41)](/filings/0001075415-25-000044.md) | not reported | [(0.04)](/filings/0001075415-26-000024.md) | [(0.38)](/filings/0001075415-26-000030.md) | [(0.68)](/filings/0001075415-25-000044.md) | not reported | [(0.18)](/filings/0001075415-26-000024.md) | [(0.16)](/filings/0001075415-26-000030.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,383](/filings/0001075415-24-000007.md) | [1,284](/filings/0001075415-25-000012.md) | [1,410](/filings/0001075415-26-000013.md) | [1,495](/filings/0001075415-26-000013.md) | [1,538](/filings/0001075415-26-000013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [12.6%](/filings/0001075415-24-000007.md) | [(1.2%)](/filings/0001075415-25-000012.md) | [(20.8%)](/filings/0001075415-26-000013.md) | [(24.8%)](/filings/0001075415-26-000013.md) | [(18.6%)](/filings/0001075415-26-000013.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001075415-24-000007.md) | [(0.07)](/filings/0001075415-25-000012.md) | [(1.23)](/filings/0001075415-26-000013.md) | [(1.55)](/filings/0001075415-26-000013.md) | [(1.19)](/filings/0001075415-26-000013.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dhc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Flat Footed LLC](/funds/1799456.md) | 2026-06-30 | $218.4m | 23,487,002 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $214.6m | 23,076,173 |  | Reduced −802,514 |
| [Silver Point Capital L.P.](/funds/1332784.md) | 2026-06-30 | $144.2m | 15,504,810 |  | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $98.5m | 10,592,743 |  | Added +1,774,923 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $90.0m | 9,675,173 |  | Added +75,470 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $83.7m | 9,002,069 |  | Added +15,157 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $65.7m | 7,060,965 |  | Added +452,468 |
| [Davidson Kempner Capital Management LP](/funds/1595082.md) | 2026-06-30 | $59.6m | 6,409,530 |  | Added +161,700 |
| [NOMURA HOLDINGS INC](/funds/1163653.md) | 2026-06-30 | $58.4m | 6,277,985 |  | Reduced −1,054,287 |
| [CARRONADE CAPITAL MANAGEMENT, LP](/funds/1866872.md) | 2026-06-30 | $57.1m | 6,139,329 |  | Added +870,894 |

## Recent filings

[All 857 filings](/companies/dhc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 17:01 ET | [SCHEDULE 13D/A](/filings/0001687639-26-000001.md) | Ownership report, active investor, amended | 0001687639-26-000001 |
| 2026-08-03 | 16:47 ET | [10-Q](/filings/0001075415-26-000030.md) | Quarterly report, period 2026-06-30 | 0001075415-26-000030 |
| 2026-08-03 | 16:24 ET | [8-K](/filings/0001075415-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-26-000029 |
| 2026-06-12 | 16:08 ET | [8-K](/filings/0001104659-26-073447.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073447 |
| 2026-06-01 | 16:03 ET | [8-K](/filings/0001104659-26-068894.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-068894 |
| 2026-05-05 | 08:05 ET | [8-K](/filings/0001104659-26-055290.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-055290 |
| 2026-05-04 | 16:56 ET | [10-Q](/filings/0001075415-26-000024.md) | Quarterly report, period 2026-03-31 | 0001075415-26-000024 |
| 2026-05-04 | 16:26 ET | [8-K](/filings/0001075415-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075415-26-000022 |
| 2026-03-19 | 16:12 ET | [DEF 14A](/filings/0001104659-26-032082.md) | Proxy statement, period 2026-06-10 | 0001104659-26-032082 |
| 2026-02-24 | 08:05 ET | [8-K](/filings/0001104659-26-018853.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018853 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001075415-26-000013.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/dfd3db4d-f585-4454-8ec1-dc1bf1a7e413)

## About the filer

- CIK: 1075415
- Tickers: DHC, DHCNI, DHCNL
- Exchange: Nasdaq
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.